This simple blood test, potentially can assess your individual risk for developing lung cancer prior to the appearance of symptoms.
Professor John Robertson, MD -
The Inspiration Behind EarlyCDT
"95% of the patients I've discussed the test with are very positive and would like to get the simple blood test."
Karl Radke, MD, Kansas
Contact Us
We would be happy to hear your feedback, and we will do our best to repond to any questions. Please let us know what you think about EarlyCDTTM and Oncimmune.
Email Oncimmune
Corporate Headquarters:
Oncimmune (USA) LLC
8960 Commerce Drive, Building #6
De Soto, Kansas 66018
(888) 583-9030
Trade Press and Cancer Advocacy Inquiries:
Tonua Fedusenko
Office: (570) 384-0450
Mobile: (302) 893-3948
tonua@tjscommunications.com
General Press Inquiries:
Debra Caruso
(212) 907-0051
debra@djccommunications.com
Oncimmune (USA) LLC | 8960 Commerce Drive Building #6 | De Soto, Kansas 66018 | 888.583.9030